Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor

The company will design and validate a test using its Exolution isolation kit, which can stratify and monitor patients in Intezyne's clinical trials of IT-139.

Q-State Subsidiary Buys Claritas Assets, Plans Relaunch of Lab to Support Drug Discovery Programs

Premium

Q-State Biosciences, which focuses on neurologic disorders, will work closely with WuXi NextCode to relaunch Claritas' exome assays.

Main menu

Drug Discovery & Development

Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor

Q-State Subsidiary Buys Claritas Assets, Plans Relaunch of Lab to Support Drug Discovery Programs

Breaking News

Danaher Q2 Revenues Rise 10 Percent, Beating Analyst Estimates

Garvan Institute's Australian Genomic Cancer Medicine Program Receives A$50M in Government Funding

ACLA Reacts to Government Report on Implementation of Medicare Pricing Law

PerkinElmer, Enzyvant Collaborate to Offer Diagnostic Testing for Farber Disease

Foundation Medicine, Guardant Health Settle Patent Infringement Suit

Akers Bio Inks Sales, Marketing Pact for HIT Assay

Featured White Papers

Sponsorships